Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, I'll be ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, ...

2024 Revenue Guidance: Raised to $16.1 billion to $16.5 billion. 2024 EPS Guidance: Raised to $2.40 to $2.50. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a 15% increase in revenues, ...

Teva Pharmaceutical Industries Ltd. has been fined nearly €463 million ($503 million) by the European Union’s antitrust ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) will be announcing its earnings results before the market opens ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) Wednesday reported a loss in its third quarter, compared to prior year's profit, despite higher revenues. However, adjusted earnings and top line ...

Allspring Global Investments Holdings LLC lessened its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free ...

Teva Pharmaceutical Industries’ shares were up 4% at 7,323 shekels today reported results for the quarter ended September 30, 2024.